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PRECLINICAL STUDIES
ctivation of p38 Mitogen-Activated
rotein Kinase Contributes to the Early
ardiodepressant Action of Tumor Necrosis Factor
ohamed Bellahcene, PHD,* Sebastien Jacquet, PHD,* Xue B. Cao, MD,* Masaya Tanno, MD, PHD,*
obert S. Haworth, PHD,* Joanne Layland, PHD,† Alamgir M. Kabir, MB, BS,† Matthias Gaestel, PHD,‡
oger J. Davis, PHD,§ Richard A. Flavell, PHD, Ajay M. Shah, MD, FESC,* Metin Avkiran, PHD, DSC,*
ichael S. Marber, PHD, FACC*
ondon, United Kingdom; Hannover, Germany; Worcester, Massachusetts; and New Haven, Connecticut
OBJECTIVES The purpose of this study was to determine whether p38 mitogen-activated protein kinase
(p38-MAPK) contributes to tumor necrosis factor-alpha (TNF)-induced contractile depression.
BACKGROUND Tumor necrosis factor has both beneficial and detrimental consequences that may result from
the activation of different downstream pathways. Tumor necrosis factor activates p38-
MAPK, a stress-responsive kinase implicated in contractile depression and cardiac injury.
METHODS In isolated hearts from mice lacking the p38-MAPK activator, MAPK kinase 3 (MKK3),
perfused at constant coronary pressure or flow, we measured the left ventricular developed
pressure (LVDP) and the relationship between end-diastolic volume and LVDP in the
presence and absence of 10 ng/ml TNF.
RESULTS Within 15 min at constant pressure, TNF significantly reduced LVDP and coronary flow
in outbred and mkk3/ mice. This early negative inotropic effect was associated with a
marked phosphorylation of both p38-MAPK and its indirect substrate, HSP27. In hearts
lacking MKK3, TNF failed to activate p38-MAPK or to cause significant contractile
dysfunction. The actions of TNF were similarly attenuated in MAPK-activated protein
kinase 2 (MK2)-deficient hearts, which have a marked reduction in myocardial p38-MAPK
protein content, and by the p38-MAPK catalytic site inhibitor SB203580 (1 mol/l). Under
conditions of constant coronary flow, the p38-MAPK activation and contractile depression
induced by TNF, though attenuated, remained sensitive to the absence of MKK3 or the
presence of SB203580. The role of p38-MAPK in TNF-induced contractile depression was
confirmed in isolated murine cardiac myocytes exposed to SB203580 or lacking MKK3.
CONCLUSIONS Tumor necrosis factor activates p38-MAPK in the intact heart and in isolated cardiac
myocytes through MKK3. This activation likely contributes to the early cardiodepressant
action of TNF. (J Am Coll Cardiol 2006;48:545–55) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.02.072Cardiology Foundation
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cumor necrosis factor-alpha (TNF) is a proinflammatory
ytokine elevated in conditions of depressed cardiac con-
ractility such as cardiac allograft rejection (1), myocardial
nfarction (2), and congestive heart failure (3). A causative,
ather than associative, role is indicated in vivo by the
See page 556
ontractile depression and remodeling that accompany sys-
emic increases in TNF (4–6). Similarly, exposure of
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n myocyte isolation.M
Manuscript received September 2, 2005; revised manuscript received December 21,
005, accepted February 7, 2006.solated hearts (7) and cardiac myocytes (8) to TNF causes
lmost immediate contractile depression in most studies (9).
n the basis of these and other observations, 3 clinical trials
ave targeted TNF in patients with heart failure. Surpris-
ngly the results of these trials suggest that anti-TNF
herapy has no benefit (10) or may even be harmful (11).
ne possible explanation for the dichotomy between the
reclinical, early clinical, and multicenter clinical trial data is
hat TNF exposure triggers beneficial (12,13) as well as
etrimental changes within the heart (14). It is likely that
he mechanisms responsible for the benefits of TNF differ
rom those that cause harm (5,14). If this is the case, it may
e possible to specifically target a downstream detrimental
ignal while leaving others intact. Among the myocardial
ignaling pathways activated by TNF is p38 mitogen-
ctivated protein kinase (p38-MAPK) (12,15). Previously
e have found that although this pathway is activated by
NF it does not mediate the protection against myocardial
nfarction that follows exposure (12,15). Under other cir-
umstances, not involving TNF, the activation of p38-APK can cause contractile dysfunction (16,17). We
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p38-MAPK in TNF-Induced Negative Inotropy August 1, 2006:545–55herefore hypothesized that p38-MAPK activation may play
role in TNF-induced contractile dysfunction.
ETHODS
reatment of animals conformed to the rules of the United
ingdom Home Office Guidance on the Operation of
nimals (Scientific Procedures) Act 1986, published by Her
ajesty’s Stationary Office, London.
KK3- and MK2-deficient mice. Mitogen-activated pro-
ein kinase kinase 3 (MKK3) and mitogen-activated protein
inase–activated protein kinase 2 (MK2) are kinases that lie
mmediately upstream and downstream of p38-MAPK,
espectively. Targeting strategies that disrupt MKK3 and
K2 are described previously (18,19). Colonies of mkk3/
nd mk2/ mice were derived from these sources by crossing
kk3/ and mk2/ mice with outbred c57BL/6 mice
Harlan, Sussex, United Kingdom). To reduce background
enetic variability (20), we used male mkk3/ and
kk3/, as well as male mk2/ and mk2/ progeny of
eterozygote matings, which whenever possible were litter
ates. In addition, outbred male c57BL/6 mice were used
o ensure that findings were not the result of within-colony
diosyncrasies (20). All gene-targeted lines were bred and
aintained in the same facility under identical conditions.
urine heart perfusion. Male mice (25 to 30 g) were
illed with pentobarbital (300 mg/kg with 150 IU heparin,
P). After midline sternotomy, hearts were rapidly excised
nd perfused as previously described (12,15,21) at a constant
ressure of 80 mm Hg with a modified Krebs-Henseleit
uffer 1 containing (in mmol/l) NaCl 118.5, NaHCO3
5.0, KCl 4.75, KH2PO4 1.18, MgSO4 1.19, D-glucose
1.0, and CaCl2 1.41 at pH 7.4, saturated with 95% O2 and
% CO2.
Left ventricular (LV) pressure was measured by a fluid-
lled balloon while hearts were paced at 580 beats/min
bpm). Additionally, some hearts were perfused under
onstant flow conditions. Constant flow was set at the value
hat generated a perfusion pressure of 80 mm Hg during the
ast 10 min of stabilization using a servo-controlled peri-
taltic pump (Gilson, Luton, United Kingdom). The aver-
ge set coronary flow was 3.4  0.4 ml/min.
In some experiments, the Frank-Starling (or end-
iastolic volume versus left ventricular developed pressure
LVDP]) relationship was determined beyond 15 min of
NF exposure by emptying the intraventricular balloon
Abbreviations and Acronyms
LVDP  left ventricular developed pressure
LVEDP  left ventricular end-diastolic pressure
MK2  mitogen-activated protein kinase-activated
protein kinase 2
MKK3  mitogen-activated protein kinase-kinase 3
p38-MAPK  p38 mitogen-activated protein kinase
TNF  tumor necrosis factor-alphand then slowly refilling in 4-l increments every 30 s. txperimental protocols. After cannulation, hearts were
tabilized for 40 min. All hearts had to fulfill the following
nclusion criteria: coronary flow between 1.5 and 4.5 ml/
in, heart rate300 beats/min (unpaced), LVDP60 mm
g, time from thoracotomy to aortic cannulation 3 min,
nd no persistent dysrhythmia during stabilization. Hearts
ere exposed to 10 ng/ml TNF (murine TNF-; Sigma
at. no. T7539) for 15 min without recirculation. Some
earts were pretreated with SB203580 (1 mol/l; Sigma)
tarting 5 min before and continuing during TNF expo-
ure. The SB203580 was dissolved in dimethyl sulfoxide
DMSO) to a final concentration of 0.01%. At the end of
he protocols, hearts were freeze-clamped and stored
t 80°C for protein analysis, or the end-diastolic volume
ersus LVDP relationship was determined during continued
NF exposure.
urine cardiomyocyte isolation. Male outbred c57BL/6,
kk3/, and mkk3/ mice (25 to 30 g) were killed with
entobarbital (300 mg/kg with 150 IU heparin, IP) and the
earts rapidly excised. Ventricular myocytes were isolated as
reviously described (22). Finally, myocytes were stored at
oom temperature in a HEPES buffer at pH 7.4 containing
in mmol/l) NaCl 130, KCl 5.4, NaH2PO4 0.4, MgCl21.4,
lucose 10, D-glucose 10.0, creatine 10, taurine 20, HEPES
0, ascorbic acid 0.03, EGTA 0.01, and CaCl2 1.0 and used
ithin 4 to 5 h.
estern blot analysis. Samples were obtained from murine
ardiomyocytes treated for 30 min with increasing concentra-
ions of TNF (0, 50, 100 ng/ml). Some cells were exposed to
oincident 1 mol/l SB203580 starting 5 min before TNF
xposure. Cells were then washed 3 times in ice-cold
hosphate-buffered solution and harvested in electrophoresis
ample (ES) buffer (250 mmol/l Tris-HCl, 4% sodium
odecyl sulfate, 10% glycerol, and 2% -mercaptoethanol,
H 6.8). Frozen heart samples were similarly homogenized
n ES buffer. Proteins, separated by electrophoresis and
ransferred to nitrocellulose membranes, were exposed to
he following primary antibodies: anti-dual phospho-p38-
APK (Thr180 and Tyr182) (Sigma) at 1:1000, anti-p38
t 1:1000, anti-HSP27 at 1:1000, anti-MKK3/6 at 1:1000,
nti–phospho-MKK3/6 (Ser189/Ser207) at 1:500 (the latter
from Santa Cruz, Wembley, United Kingdom), and anti–
hospho-HSP27 (Ser83) at 1:400 (Amersham, Little Chal-
ont, United Kingdom), before appropriate second anti-
ody and ECL detection. Autophotographic images of
estern blots were scanned and quantified using NIH
mage analysis software, and results are expressed as
ean  SEM.
urine cardiomyocyte contraction. Freshly isolated mu-
ine cardiomyocytes were randomly assigned to 1 of the
ollowing groups: control, TNF (10 ng/ml for 30 min); SB
1 mol/l SB203580 for 35 min), and SB  TNF. To
ssess the reversibility of TNF-induced effects, myocytes
ere washed 3 times with Tyrode’s solution (see the
ollowing text) and allowed to recover for 45 min. All
reatments were performed at room temperature and away
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*Comparisons between the groups for the given parameters (1-way analysis of variance).
LVDP  left ventricular developed pressure; TNF  tumor necrosis factor.
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August 1, 2006:545–55 p38-MAPK in TNF-Induced Negative Inotropyigure 1. Effect of tumor necrosis factor-alpha (TNF) (10 ng/ml) on mkk3/ (KO) and mkk3/ (WT) hearts during coronary perfusion under
onditions of constant pressure. Data represented by mean  SEM; n  6 per group. (A) Left ventricular developed pressure (LVDP) before and during
5 min exposure to TNF. (B) Left ventricular volume versus LVDP measured after at least 15 min of TNF. (C) Coronary flow before and during TNF.
D) Upper part shows representative Western blots of total and phosphorylated p38-MAPK and HSP27 in hearts exposed to TNF for 15 min. Activationable 1. Baseline Characteristics of Mouse Hearts (Mean  SD)
Outbred
Outbred
 TNF mkk3/
mkk3/
 TNF mkk3/
mkk3/
 TNF mk2/ mk2/ p*
42 12 12 12 12 12 9 9
ody weight (g) 28.6  0.4 29.0  0.7 27.3  0.7 27.5  0.5 27.5  0.5 26.1  1.8 27.7  0.5 27.4  0.5 0.26
aseline coronary flow (ml/min) 2.8  0.1 2.9  0.1 2.8  0.1 3.1  0.1 3.0  0.1 2.8  0.1 2.8  0.1 3.0  0.2 0.44
VDP (mm Hg) 71.3  0.5 72.9  1.4 72.3  1.4 71.1  0.9 69.4  0.9 69.3  1.1 70  1.6 68.9  2.4 0.12
iastolic pressure (mm Hg) 6.5  0.2 7.5  0.3 7.1  0.3 6.6  0.4 6.2  0.3 7.1  0.4 5.8  0.5 6.7  0.7 0.14f p38-MAPK is reflected in the phosphorylation of HSP27. Lower part shows quantitative data expressed as fold increase relative to baseline (mean 
EM; n  3). TNF induces a robust activation of p38-MAPK in mkk3/ but not in mkk3/ hearts.
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p38-MAPK in TNF-Induced Negative Inotropy August 1, 2006:545–55rom light before transferring cells to a superfusion chamber
ith a glass cover slip base resting on the stage of an
nverted microscope (Nikon, Tokyo, Japan). Cells were
uperfused at 1 to 2 ml/min at 37°C, with the HEPES-
ased buffer supplemented with 10 ng/ml TNF, 1 mol/l
B203580, or both according to the preincubation group.
yocytes were observed using a 40 Fluor objective (Nikon),
igure 2. Effect of tumor necrosis factor-alpha (TNF) (10 ng/ml) on
onditions of constant flow. Data represented by mean  SEM; n  6 p
xposure to TNF. (B) Left ventricular volume versus LVDP measured aft
NF. (D) Upper part shows representative Western blots of total and ph
ower part depicts quantitative data expressed as fold increase relative to
kk3/ but not in mkk3/ hearts under constant flow conditions; hownd the image was relayed via a video camera and frame arabber to a PC running IonWizard software (IonOptix,
ilton, Massachusetts). Myocytes were selected according
o previous criteria (8) and sarcomere length recorded
uring field stimulation at 0.5 Hz (MyoPacer; IonOptix) by
ideo analysis (IonOptix).
tatistical analysis. Baseline characteristics, as well as
arcomere shortening data, were compared using 1-way
/ (KO) and mkk3/ (WT) hearts during coronary perfusion under
oup. (A) Left ventricular developed pressure (LVDP) before and during
east 15 min of TNF. (C) Perfusion pressure measured before and during
orylated p38-MAPK and HSP27 in hearts exposed to TNF for 15 min.
ine (mean  SEM; n  3). TNF induces activation of p38-MAPK in
this effect was less pronounced than under constant pressure (Fig. 1).mkk3
er gr
er at l
osph
baselnalysis of variance (ANOVA) followed by Newman-
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August 1, 2006:545–55 p38-MAPK in TNF-Induced Negative Inotropyeuls post hoc analysis. Hemodynamic variables were
ompared by 2-way repeated measures ANOVA with
ime and group as factors. Results are shown as mean 
EM, except where otherwise indicated, and p  0.05
as considered significant.
ESULTS
he baseline characteristics of the mice and hearts are
igure 3. Effect of tumor necrosis factor-alpha (TNF) (10 ng/ml) on mk2
onstant pressure. Data represented by mean SEM. (A) Left ventricular dev
efore and during TNF. (C) Upper part shows representative Western blots
or 15 min. Lower part shows quantitative data expressed in arbitrary units as p
 3), because total p38-MAPK is altered by the mk2 genotype. Consequent
KK3 is preferentially activated over MKK6 by TNF, with detectable phohown in Table 1. There was no difference between mutbred c57BL/6, mkk3/, mkk3/, mk2/, and
k2/ mice.
NF in mkk3/ hearts. Under constant pressure per-
usion, TNF (10 ng/ml) induced a rapid decrease of
VDP in outbred c57BL/6 and mkk3/ hearts that
eached 50% after 15 min (Fig. 1A). However, a similar
ecrement was not seen in mkk3/ hearts, with contractile
erformance remaining similar to time-matched outbred
O) and mk2/ (WT) hearts during coronary perfusion under conditions of
d pressure (LVDP) before and during exposure to TNF. (B) Coronary flow
al and phosphorylated p38-MAPK and MKK3/6 in hearts exposed to TNF
horylation increase related to total amount for a given protein (mean SEM;
-MAPK dual phoshorylation is less pronounced in mk2/ than in mk2/.
MKK3/6 signal in both mk2/ and mk2/./ (K
elope
of tot
hosp
ly, p38kk3/ and mkk3/ control mice. The TNF-induced
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p38-MAPK in TNF-Induced Negative Inotropy August 1, 2006:545–55ontractile depression was further confirmed by the end-
iastolic volume versus LVDP relationship (Fig. 1B). Tu-
or necrosis factor (10 ng/ml) significantly depressed con-
raction, with severely blunted contractile recruitment at
alloon volumes greater than 12 to 16 l, corresponding to
igure 4. Effect of 1 mol/l SB203580 (SB) on tumor necrosis factor-alph
ere perfused under constant pressure or constant flow conditions. SB w
10 ng/ml) for 15 min, SB (1 mol/l), or DMSO (0.01%) for 20 min. D
ressure (LVDP) and (B) coronary flow with constant pressure perfusion. (
B reduced TNF-induced contractile dysfunction with constant pres
NF-induced coronary vasoconstriction. (E) Upper part shows represen
earts exposed to TNF, SB, DMSO, and SB  TNF under constan
ncrease related to total amount for a given protein (mean  SEM; n nd-diastolic pressure of 20 to 30 mm Hg, in both c57BL/6 autbred and mkk3/ but not mkk3/ hearts (Fig. 1B).
o further explore the role of p38-MAPK, we measured its
ual phosphorylation, as well as HSP27 phosphorylation,
fter 15 min exposure to TNF (10 ng/ml) (Fig. 1D). The
NF-induced negative inotropy in mkk3/ hearts was
F)-induced contractile dysfunction. Hearts from outbred C56BL/6 mice
ubilized in dimethyl sulfoxide (DMSO). Hearts were exposed to TNF
epresent mean  SEM; n  6 per group. (A) Left ventricular developed
VDP and (D) perfusion pressure recorded under constant flow conditions.
and to a lesser extent with constant flow. Surprisingly, SB reversed
Western blots of total and phosphorylated p38-MAPK and HSP27 in
sure. Lower part depicts quantitative data expressed as phosphorylation
A  normalization not appropriate.a (TN
as sol
ata r
C) L
sure
tative
t presssociated with a significant phophorylation of both p38-
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August 1, 2006:545–55 p38-MAPK in TNF-Induced Negative InotropyAPK and HSP27 (24-fold and 8-fold, respectively)
nder constant perfusion pressure conditions. However, in
kk3/ hearts, resistant to the negative inotropic effect of
NF, there was no detectable p38-MAPK activation.
nterestingly, our coronary flow data (Fig. 1C) highlighted
he acute vasoconstrictive action of TNF reported else-
here: (9,23) TNF induced a40% reduction in coronary
ow in all treated hearts, which, although present, tended to
e less marked in mkk3/ hearts. We have recently shown
21) that reductions in coronary flow of a similar magnitude
ause myocardial p38-MAPK activation after 60 or 120
in. Although we did not measure p38-MAPK activation
fter just 15 min of flow reduction, the possibility remains
hat, under constant pressure conditions, the observed
38-MAPK activation is the result of TNF-induced
oronary vasoconstriction rather than a direct action on the
yocardium. To explore this possibility, we measured
38-MAPK activation and contraction during TNF ex-
osure with constant coronary flow (Fig. 2). The cardiode-
ressant action of TNF was less marked than under
onstant pressure (compare Fig. 2A with Fig. 1A) but
emained significant and was especially evident when con-
ractile reserve was examined by incremental increases in LV
alloon volume (Fig. 2B). Furthermore, in keeping with
ndings in Figure 1, TNF failed to reduce contractility in
kk3/hearts (Figs. 2A and 2B). Under constant flow
onditions, TNF-induced vasoconstriction manifested as a
ise in coronary perfusion pressure (Fig. 2C), which may
ave partially offset the cardiodepressant action of TNF
hough the physiologically antagonistic action of the Gregg
ffect (24). Under constant flow, p38-MAPK activation was
ess pronounced than under constant pressure (compare
ig. 2D with Fig. 1D). Taken together, these results suggest
hat TNF-induced contractile dysfunction may be partially
ependent on coronary flow. However TNF also has a
irect cardiodepressant action independent of changes in
oronary flow. Importantly, these direct and indirect effects
ct synergistically and are associated with p38-MAPK
ctivation. This association was further explored using an
ndependent mouse line.
NF in mk2/ hearts. The disruption of the mk2 allele
s associated with a marked reduction in myocardial total
38-MAPK (25). Therefore, to further confirm the role of
38-MAPK in TNF-induced negative inotropy we used
k2/ and mk2/ mouse hearts perfused with a constant
ressure. As shown in Figure 3A, TNF reduced contrac-
ility by 30% in mk2/ but only by 15% in mk2/.
ccordingly, mk2/ hearts contained less than half the
38-MAPK of mk2/ hearts (Fig. 3C) (25). The reduc-
ions in coronary flow (Fig. 3B) were similar to those seen
n outbred c57BL/6 and mkk3/ hearts (Fig. 1B). Similar
evels of MKK3 and MKK6 protein were found in mk2/
nd mk2/ hearts (Fig. 3C). Nonetheless, it seems that
KK3 is preferentially activated over MKK6 by TNF
Fig. 3C), a finding in keeping with Figure 1D and previous
eports in other cell types (26). Consequently, TNF Tnduces p38-MAPK dual phosphorylation in both mk2/
nd mk2/ hearts, but the reduced levels of p38-MAPK in
he knockout hearts result in less dual phosphorylation.
nce again, a mouse line with defective p38-MAPK
ctivation in response to TNF is relatively resistant to
NF-induced cardiac depression.
ffects of SB203580. To complement the experiments in
argeted mouse lines, we investigated the effect of the
38-MAPK catalytic site inhibitor SB203580 (1 mol/l),
n TNF-induced cardiac dysfunction in outbred c57BL/6
ice. With constant pressure perfusion, SB203580 attenu-
ted TNF-induced dysfunction (Fig. 4A). Neither
B203580 alone nor DMSO (0.01%) had any effect on
ontractility (Figs. 4A and 4C). However SB203580, but
ot DMSO, attenuated the contractile depression caused by
igure 5. Effect of tumor necrosis factor-alpha (TNF) (10 ng/ml) on
urine cardiomyocytes. (A) Representative Western blots of total and
hosphorylated p38-MAPK from outbred C57BL/6 mouse cardiomyo-
ytes preincubated for 30 min with increasing concentrations of TNF (0,
0, 100 ng/ml). Lower panel shows quantitative data expressed as fold
ncrease of phosphorylation relative to control (mean  SEM; n  3).
hese cells exhibited a substantial basal p38-MAPK dual phosphorylation,
nd TNF, even at high doses, only induced a 3-fold increase in
38-MAPK dual phosphorylation. (B) Representative Western blots of
otal and phosphorylated p38-MAPK from C57BL/6 mouse cardiomyo-
ytes and perfused hearts both exposed to TNF (10 ng/ml) for 15 min
n  3). Cardiomyocytes exhibited considerable basal p38-MAPK dual
hosphorylation which was absent in perfused hearts. Furthermore, p38-
APK dual phosphorylation in perfused hearts was greater than in
ardiomyocytes (25-fold vs. 3-fold increase, respectively).NF. Surprisingly, SB203580, in contrast to the absence
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p38-MAPK in TNF-Induced Negative Inotropy August 1, 2006:545–55f MKK3, also reversed the vasoconstrictive action of
NF (Fig. 4B), consistent with the observation that
igure 6. Effects of tumor necrosis factor-alpha (TNF) (10 ng/ml) and SB20
rom outbred C57BL/6, mkk3/, and mkk3/ mice underwent the follow
1 mol/L; n  25, 29, and 34, respectively); and SB for 35 min starting 5 m
reatments, some cells were allowed to recover for 45 min in Tyrode’s buffer t
alues are mean  SEM. (A) Experimental traces showing sarcomere co
reincubated for 30 min with TNF (10 ng/ml). (B) Normalized sarcomere c
arcomere relengthening. Continued on next page.B203580 relaxes smooth muscle cell contraction through cnhibition of p38-MAPK (27). By inference, it is likely that
KK3 is not responsible for p38-MAPK activation in this
(SB, 1 mol/l) on mkk3/ cardiomyocytes. Freshly isolated cardiomyocytes
posures: TNF (10 ng/ml; n  24, 29, and 32, respectively) for 30 min; SB
ore TNF exposure (n  20, 28, and 32, respectively). After TNF and SB
ss the reversibility of the contractile deficit (n  16, 13, and 24, respectively).
ion in outbred C57BL/6, mkk3/, and mkk3/ mouse cardiomyocytes
ction amplitude, maximal rate of sarcomere contraction, and maximal rate of3580
ing ex
in bef
o asse
ntract
ontraase. Under constant flow conditions, pretreatment with
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August 1, 2006:545–55 p38-MAPK in TNF-Induced Negative InotropyB203580 also abolished the TNF effect on contractility
Fig. 4C) and inhibited the rise in perfusion pressure (Fig. 4D).
s shown in Figure 4E, SB203580 blunted p38-MAPK
ual phosphorylation as well as HSP27 phosphorylation.
his reduction in dual phosphorylation may reflect the
omponent arising from coronary vasoconstriction (Figs.
D and 2D), in keeping with our previous findings (15,21).
aken together these results suggest that SB203580 reduces
oth direct and indirect effects of TNF on contractility,
nd that this seems to occur through inhibition of TNF-
nduced p38-MAPK activity.
haracterization of TNF effects in murine cardiomyo-
ytes. To clarify the effect of TNF without the confounding
ffect on coronary flow/pressure, we measured murine cardio-
yocyte shortening in response to TNF. In cardiomyocytes
rom adult c57BL/6 mice we noted a substantial basal p38-
igure 6 Continued. (C) Characterization of SB effect on TNF-ind
epresentative Western blots of total and phosphorylated p38-MAPK and
10 ng/ml) for 15 min, SB (1 mol/l) for 35 min, and SB for 35 min given
s fold increase of phosphorylation relative to control (mean  SEM; n 
ut not in mkk3/ myocytes.APK dual phosphorylation (Fig. 5A). In these cells, 10 sg/ml TNF increased p38-MAPK dual phosphorylation
3-fold, and higher concentrations of TNF did not produce
urther p38-MAPK activation. As shown in Figure 5B, the
38-MAPK activation status in whole heart displays a greater
ynamic range than in cardiomyocytes, owing to a combina-
ion of lower basal and greater TNF-stimulated activation.
NF effects on mkk3/ cardiomyocytes. Cardiomyo-
ytes from adult outbred c57BL/6, mkk3/, and mkk3/
ice were examined. The effects of TNF (10 ng/ml) on
ontractility were assessed by measuring sarcomere shorten-
ng in the presence and absence of SB203580 (1 mol/l).
igures 6A and 6B both show that TNF induced a 50%
eduction in contraction amplitude in outbred C57BL/6
nd mkk3/ myocytes. This effect was at least partially
ttenuated in mkk3/ myocytes. Tumor necrosis factor
aused a marked decrease of the maximal rates of sarcomere
p38-MAPK activation in murine cardiomyocytes. Upper part shows
27 in mkk3/ and mkk3/ murine cardiomyocytes exposed to TNF
in before TNF treatment. Lower part shows quantitative data expressed
portantly, TNF treatment induced p38-MAPK activation in mkk3/uced
HSP
5 mhortening and relengthening (Fig. 6B). In addition, these
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p38-MAPK in TNF-Induced Negative Inotropy August 1, 2006:545–55ffects were reversible on TNF wash-out. Surprisingly,
B203580 completely inhibited TNF-induced contractile
epression in outbred c57BL/6, mkk3/, as well as mkk3/
yocytes. Figure 6C shows that TNF (10 ng/ml) exposure
nduced p38-MAPK activation in mkk3/ but not in
kk3/ myocytes. Pretreatment with SB203580 inhibited
NF-induced p38-MAPK activity in mkk3/ cells, based
n HSP27 phosphorylation, without any effect on mkk3/
ells. Taken together, these results confirmed a direct negative
notropic effect of TNF mediated, at least in part, by
38-MAPK. Pretreatment of cardiomyocytes with SB203580
otally reverses TNF-induced negative inotropy.
ISCUSSION
n the present study, we show that the early contractile
ysfunction induced by TNF is dependent on myocardial
38-MAPK activation. This conclusion, based on 2 differ-
nt targeted mouse lines and a pharmacologic inhibitor, is
onsistent with other recent studies implicating myocardial
38-MAPK activation in contractile dysfunction (16,17,28).
urthermore, at least 1 of the early benefits of TNF is
ndependent of p38-MAPK activation (12). Taken together,
hese findings suggest that inhibition of p38-MAPK activation
ownstream of TNF may provide greater specificity than
nterventions that target TNF.
NF and p38-induced cardiac dysfunction. The acti-
ation of p38-MAPK by genetic or other means has been
hown to cause contractile dysfunction (16,17). Although
he exact underlying mechanism is not known, it does not
eem to involve alterations in the calcium transient (16,17),
direct phosphorylation of troponin I, or a fall in pH (16)
ut rather a decrease in myofilament calcium sensitivity,
nd/or force production, by another mechanism (16,17).
he mechanism by which TNF causes early contractile
epression in vitro, despite being more thoroughly studied,
emains similarly uncertain, with evidence supporting both
alcium and myofilament-dependent and -independent ef-
ects (9). However, greater consensus exists regarding the
roximal signaling pathway responsible for TNF-induced
ontractile depression, which likely includes TNF receptor
-dependent activation of sphingomyelinases to form cer-
mide (9). This pathway also mediates the cardioprotection
hat follows TNF exposure (29) and leads to p38-MAPK
ctivation in multiple cell types. Our data suggest that the
38-MAPK activation downstream of this pathway results
n contractile depression, whereas other data suggest it does
ot lead to cardioprotection (12). Therefore, inhibition of
38-MAPK is likely to achieve greater physiologic specific-
ty than inhibition of sphingomyelinases. Furthermore,
here is accumulating evidence that inhibiting p38-MAPK
s a valid strategy.
Previous studies have examined the immediate effect of
harmacologic inhibition of p38-MAPK on basal con-
raction or contractile dysfunction induced by arsenite
16,17). These findings, together with our own, which pmployed complementary nonpharmacologic approaches
n the whole heart, suggest that p38-MAPK is a valid and
ealistic target in heart failure and that inhibition could
mprove short-term contractility and perhaps disease
rogression (30).
Findings in models of longer-term contractile dysfunc-
ion have also generally shown improvements with p38-
APK inhibition. However interpreting results of these
tudies is complex. p38-MAPK inhibition occurred early in
he disease process and caused beneficial remodeling
31,32), making it is difficult to dissect the contribution of
mproved contraction from that caused by more favorable
eft ventricular morphology. Furthermore, the elegant re-
ent study by Li et al. (32) demonstrates that p38-MAPK is
ritical to an autocrine loop because it lies both upstream
nd downstream of TNF released from cardiac myocytes.
his finding further complicates interpretation of underly-
ng mechanisms but reinforces potential clinical utility.
he mechanisms of p38-MAPK activation in response to
NF. In this and our previous study (15), the activation of
38-MAPK seen in response to TNF is MKK3 dependent.
his observation is in keeping with findings in other cell types
26). The mechanism by which TNF activates MKK3 is not
nown for certain but may involve oxidation-sensitive modu-
ation of the upstream kinase apoptosis signal-regulating kinase
(ASK1) by thioredoxin (33).
Because TNF has been shown to induce coronary
onstriction (24), we had to verify whether p38-MAPK–
ediated effects of TNF on contractility were due to a
irect effect of TNF on cardiomyocytes or whether instead
NF exerts this effect indirectly through flow-contraction
atching. Using constant pressure versus constant flow
odels of heart perfusion, we showed that direct and
ndirect effects of TNF on cardiomyocytes act in concert.
n addition, it is likely that TNF-induced coronary vaso-
onstriction also contributes to p38-MAPK activation, be-
ause dual phosphorylation is greater under constant coro-
ary pressure than in constant coronary flow conditions
compare Figs. 1 and 2). Furthermore, the reductions in
oronary flow seen with TNF may have been sufficient to
ynergistically dual phosphorylate/activate p38-MAPK
hrough an independent mechanism that may involve auto-
hosphorylation and therefore result in partial sensitivity to
nhibition of p38-MAPK catalytic activity with SB203580
15). Alternatively, the reduction in p38-MAPK dual phos-
horylation may simply result from the lack of coronary
asoconstriction and consequent normalization of flow in
he presence of TNF with SB203580. The ability of
B203580 to prevent coronary vasconstriction may be a
eflection of TNF-induced p38-MAPK activation within
ascular smooth muscle which is known to cause contraction
27). However, this agent also inhibits a number of other
inases and proteins (34), which may explain why it im-
roved contractility in mkk3/ cardiomyocytes in the
bsence of detectable TNF-induced p38-MAPK dual
hosphorylation (Figs. 6B and 6C). If the abolition of
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August 1, 2006:545–55 p38-MAPK in TNF-Induced Negative Inotropyoronary vasoconstriction is the result of p38-MAPK inhi-
ition within the vasculature, this implies that the mecha-
isms of activation differ from those within the myocar-
ium, because they are not abrogated by the absence of
KK3 or MK2.
In this study, we show that p38-MAPK activation is at
east in part responsible for the early cardiodepressant action
f TNF. Although TNF is implicated in the pathogen-
sis of heart failure, clinical trials targeting this cytokine
ave not shown a benefit (10,11), possibly because TNF is
nvolved in adaptive signaling (12,13). Our results, together
ith other findings (12,32), imply that p38-MAPK may
epresent a more favorable, but related, target that is already
nder investigation in a number of other disease areas (35).
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